Pharmacologic therapy of pulmonary vasoconstriction in acute pulmonary embolism
- PMID: 14693646
- DOI: 10.1213/01.ANE.0000077707.55641.F9
Pharmacologic therapy of pulmonary vasoconstriction in acute pulmonary embolism
Comment on
-
Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism.Anesth Analg. 2003 Aug;97(2):341-354. doi: 10.1213/01.ANE.0000068983.18131.F0. Anesth Analg. 2003. PMID: 12873915 Review. No abstract available.
References
-
- Stratmann G, Gregory G A. Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism. Anesth Analg 2003; 97: 341–54.
-
- Tanus-Santos JE, Theodorakis MJ. Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism? American Journal of Respiratory Medicine 2002; 1: 167–76.
-
- Tanus-Santos JE, Moreno H Jr, Zappellini A, de Nucci G. Small-dose inhaled nitric oxide attenuates hemodynamic changes after pulmonary air embolism in dogs. Anesth Analg 1999; 88: 1025–9.
-
- Tanus-Santos JE, Moreno H Jr, Moreno RA, et al. Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs. Intensive Care Med 1999; 25: 983–9.
-
- Tanus-Santos JE, Gordo WM, Udelsmann A, et al. Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs. Chest 2000; 118: 175–9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
